CN109674875A - Oral ulcer nursing essence - Google Patents
Oral ulcer nursing essence Download PDFInfo
- Publication number
- CN109674875A CN109674875A CN201910157509.XA CN201910157509A CN109674875A CN 109674875 A CN109674875 A CN 109674875A CN 201910157509 A CN201910157509 A CN 201910157509A CN 109674875 A CN109674875 A CN 109674875A
- Authority
- CN
- China
- Prior art keywords
- extract
- essence
- nurses
- canker sore
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000474 nursing effect Effects 0.000 title abstract description 13
- 208000007117 Oral Ulcer Diseases 0.000 title abstract 4
- 208000002399 aphthous stomatitis Diseases 0.000 title abstract 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 72
- 239000000284 extract Substances 0.000 claims abstract description 64
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims abstract description 48
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims abstract description 30
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 24
- 235000003599 food sweetener Nutrition 0.000 claims abstract description 24
- 239000003765 sweetening agent Substances 0.000 claims abstract description 24
- 239000011701 zinc Substances 0.000 claims abstract description 24
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 24
- 239000002562 thickening agent Substances 0.000 claims abstract description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 22
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 claims abstract description 17
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims abstract description 15
- 229960000458 allantoin Drugs 0.000 claims abstract description 15
- 239000008367 deionised water Substances 0.000 claims abstract description 15
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 15
- 239000003755 preservative agent Substances 0.000 claims abstract description 15
- 230000002335 preservative effect Effects 0.000 claims abstract description 15
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229960004711 sodium monofluorophosphate Drugs 0.000 claims abstract description 9
- 239000010677 tea tree oil Substances 0.000 claims abstract description 8
- 229940111630 tea tree oil Drugs 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 5
- 239000000203 mixture Substances 0.000 claims description 39
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 36
- 235000013824 polyphenols Nutrition 0.000 claims description 36
- 208000020670 canker sore Diseases 0.000 claims description 35
- XDQITMCFPPPMBC-TUANDBMESA-N scutelloside Natural products OC[C@H]1O[C@@H](O[C@@H]2O[C@@H]3C[C@H]4[C@H](O)[C@@H](O)[C@@](O)(CO3)[C@@H]24)[C@H](O)[C@@H](O)[C@@H]1O XDQITMCFPPPMBC-TUANDBMESA-N 0.000 claims description 32
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 28
- 239000000872 buffer Substances 0.000 claims description 28
- 239000000463 material Substances 0.000 claims description 28
- 241001057584 Myrrha Species 0.000 claims description 25
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 16
- 235000005152 nicotinamide Nutrition 0.000 claims description 16
- 239000011570 nicotinamide Substances 0.000 claims description 16
- 229960003966 nicotinamide Drugs 0.000 claims description 16
- RCEAADKTGXTDOA-UHFFFAOYSA-N OS(O)(=O)=O.CCCCCCCCCCCC[Na] Chemical compound OS(O)(=O)=O.CCCCCCCCCCCC[Na] RCEAADKTGXTDOA-UHFFFAOYSA-N 0.000 claims description 15
- 206010002198 Anaphylactic reaction Diseases 0.000 claims description 14
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 claims description 14
- 208000003455 anaphylaxis Diseases 0.000 claims description 14
- 239000003795 chemical substances by application Substances 0.000 claims description 14
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 14
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 14
- 238000004090 dissolution Methods 0.000 claims description 13
- IWHVCHNCTHGORM-UHDJGPCESA-M potassium;(e)-3-phenylprop-2-enoate Chemical compound [K+].[O-]C(=O)\C=C\C1=CC=CC=C1 IWHVCHNCTHGORM-UHDJGPCESA-M 0.000 claims description 13
- 239000003921 oil Substances 0.000 claims description 11
- 235000007297 Gaultheria procumbens Nutrition 0.000 claims description 9
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 9
- 241000736246 Pyrola Species 0.000 claims description 9
- 239000010495 camellia oil Substances 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- 239000011734 sodium Substances 0.000 claims description 9
- 229910052708 sodium Inorganic materials 0.000 claims description 9
- 229960003500 triclosan Drugs 0.000 claims description 9
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims description 7
- 241001164374 Calyx Species 0.000 claims description 7
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 7
- 241000124033 Salix Species 0.000 claims description 7
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims description 7
- 239000006071 cream Substances 0.000 claims description 7
- 229940041616 menthol Drugs 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- 239000012047 saturated solution Substances 0.000 claims description 7
- 230000015572 biosynthetic process Effects 0.000 claims description 6
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 6
- 239000010931 gold Substances 0.000 claims description 6
- 229910052737 gold Inorganic materials 0.000 claims description 6
- 239000001509 sodium citrate Substances 0.000 claims description 6
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical group O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 6
- 239000000243 solution Substances 0.000 claims description 6
- 229930182470 glycoside Natural products 0.000 claims description 4
- 150000002338 glycosides Chemical class 0.000 claims description 4
- 235000014676 Phragmites communis Nutrition 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 240000008042 Zea mays Species 0.000 claims description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 2
- 150000001720 carbohydrates Chemical class 0.000 claims description 2
- 235000005822 corn Nutrition 0.000 claims description 2
- 241000894007 species Species 0.000 claims description 2
- 239000003643 water by type Substances 0.000 claims description 2
- 244000269722 Thea sinensis Species 0.000 claims 6
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 claims 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 claims 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims 1
- 240000000111 Saccharum officinarum Species 0.000 claims 1
- 235000007201 Saccharum officinarum Nutrition 0.000 claims 1
- 229930016911 cinnamic acid Natural products 0.000 claims 1
- 235000013985 cinnamic acid Nutrition 0.000 claims 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 claims 1
- 239000011591 potassium Substances 0.000 claims 1
- 229910052700 potassium Inorganic materials 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 11
- 208000004371 toothache Diseases 0.000 abstract description 3
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 abstract description 2
- 230000002411 adverse Effects 0.000 abstract description 2
- 229910001424 calcium ion Inorganic materials 0.000 abstract description 2
- 230000036541 health Effects 0.000 abstract description 2
- 239000000419 plant extract Substances 0.000 abstract description 2
- 230000002265 prevention Effects 0.000 abstract 2
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 abstract 1
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 abstract 1
- 206010018276 Gingival bleeding Diseases 0.000 abstract 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 abstract 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 239000000043 antiallergic agent Substances 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 239000006172 buffering agent Substances 0.000 abstract 1
- 239000010634 clove oil Substances 0.000 abstract 1
- 229940030275 epigallocatechin gallate Drugs 0.000 abstract 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 abstract 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 abstract 1
- 208000028169 periodontal disease Diseases 0.000 abstract 1
- 229960004063 propylene glycol Drugs 0.000 abstract 1
- 235000013772 propylene glycol Nutrition 0.000 abstract 1
- 239000009637 wintergreen oil Substances 0.000 abstract 1
- 241001122767 Theaceae Species 0.000 description 31
- 238000000034 method Methods 0.000 description 16
- 208000002193 Pain Diseases 0.000 description 15
- 238000012360 testing method Methods 0.000 description 12
- 238000000605 extraction Methods 0.000 description 11
- 240000007311 Commiphora myrrha Species 0.000 description 10
- 235000006965 Commiphora myrrha Nutrition 0.000 description 10
- 235000007265 Myrrhis odorata Nutrition 0.000 description 10
- 208000025865 Ulcer Diseases 0.000 description 9
- 231100000397 ulcer Toxicity 0.000 description 9
- 235000019198 oils Nutrition 0.000 description 8
- 210000000214 mouth Anatomy 0.000 description 7
- 239000004376 Sucralose Substances 0.000 description 6
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical group O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 6
- 235000019408 sucralose Nutrition 0.000 description 6
- 239000011670 zinc gluconate Substances 0.000 description 6
- 235000011478 zinc gluconate Nutrition 0.000 description 6
- 229960000306 zinc gluconate Drugs 0.000 description 6
- 239000003292 glue Substances 0.000 description 5
- 239000008159 sesame oil Substances 0.000 description 5
- 235000011803 sesame oil Nutrition 0.000 description 5
- 230000000855 fungicidal effect Effects 0.000 description 4
- 239000000417 fungicide Substances 0.000 description 4
- 239000007937 lozenge Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 150000003431 steroids Chemical class 0.000 description 4
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 229960003260 chlorhexidine Drugs 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 208000030194 mouth disease Diseases 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 208000010266 Aggressive Periodontitis Diseases 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- NTONWZCHBHSFIE-UHFFFAOYSA-N C1=CNC=C1.N.[Cl+] Chemical compound C1=CNC=C1.N.[Cl+] NTONWZCHBHSFIE-UHFFFAOYSA-N 0.000 description 1
- RZYKUPXRYIOEME-UHFFFAOYSA-N CCCCCCCCCCCC[S] Chemical compound CCCCCCCCCCCC[S] RZYKUPXRYIOEME-UHFFFAOYSA-N 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 235000019738 Limestone Nutrition 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- DMGNFLJBACZMRM-UHFFFAOYSA-N O[P] Chemical compound O[P] DMGNFLJBACZMRM-UHFFFAOYSA-N 0.000 description 1
- 229920002413 Polyhexanide Polymers 0.000 description 1
- ZSGLLHYOHOOSQS-UHFFFAOYSA-N [Na].[P].[F] Chemical compound [Na].[P].[F] ZSGLLHYOHOOSQS-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000003139 biocide Substances 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000000739 chaotic effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000013383 initial experiment Methods 0.000 description 1
- 239000006028 limestone Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000021332 multicellular organism growth Effects 0.000 description 1
- 201000006727 periodontosis Diseases 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 235000018648 unbalanced nutrition Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/758—Zanthoxylum, e.g. pricklyash
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Physiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nutrition Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to the technical field of health care and nursing functional products, in particular to oral ulcer nursing essence, wherein the components of each raw material comprise an epigallocatechin gallate extract, an anti-allergy agent, a radix zanthoxyli extract, sodium monofluorophosphate, nicotinamide, propylene glycol, wintergreen oil, clove oil, tea tree oil, a sweetening agent, sodium dodecyl sulfate, glycerol, active zinc, a freshener, a thickening agent, a preservative, a buffering agent, allantoin and the balance of deionized water; the invention provides the oral ulcer care essence which is prepared from the raw materials without antibiotics, is a pure natural plant extract, has good biocompatibility, does not generate biological rejection reaction of oral tissues, and has no adverse side effect; has definite prevention and treatment effects on gingival bleeding, periodontal disease and sensitive toothache; when the quantitative sodium monofluorophosphate in the solution of the oral ulcer care essence is completely dissolved in water, calcium ions in the hydroxyapatite of the teeth are dissolved in a fluorion state and have the function of moth prevention.
Description
Technical field
The present invention relates to caring functional product technical fields, and in particular to canker sore nurses Essence.
Background technique
The health status in oral cavity be human health development portrayal, modern diet only demand it is ready-made ask speed, unbalanced nutrition.Add
Upper operating pressure is big, and the time of having a rest is chaotic.Canker sore is easy to happen.Past, traditional treatment ulcer method only use fungicide,
Based on antibiotic.Specific aim is not strong, and receptor does not dock.Not only therapeutic effect is bad, even more increases pain.And abuse antibiosis
Element causes disruption of ecological balance, brings on a disaster for environment.
Treatment Ulcer medicine is most of by biocide agent allusion quotation (I) and multistage quaternary ammonium salt cationic fungicide at present, such as: western pyrrole chlorine
Ammonium (CPC), chlorhexidine, (PHMB) etc..These substances are to kill based on the bacterium of surface, but effect is poor, not can solve ulcers pain
It is bitter.There are also steroids patch is used, effect is equally not all right.These are unable to counterpart chamber mucous membrane at all and generate healing effect, can only increase
Add treatment time, increases patient suffering.
In the treatment Ulcer medicine be made of fungicide or hormone, although skin surface flora can be killed, mouth is had ignored
Countless bacterium colonies existing for the chamber moment.What these beneficial and harmful floras did not under normal circumstances injure us in body, greatly
Part flora is to aid in body growth.When certain bacterial flora alternation, our body own systems, which can be generated, can swash reaction, meeting
Change hormonal variation.Such as generate certain and do not accommodate a degree of physical reaction, to increase the treatment of mouth disease
Time.
Summary of the invention
Therefore, the present invention provides canker sore to nurse Essence, does not have antibiotic group in raw material at not injuring mouth
Chamber, without adverse side effect;And to bleeding gums, periodontosis, sensitivity, which is had a toothache, definite prophylactic-therapeutic effect.
In order to achieve the above object, the present invention is achieved by the following technical programs:
Canker sore nurses Essence, wherein each material composition is by weight: Myrrha extract 2~4%, anti-anaphylaxis agent
0.6~0.9%, Radix Zanthoxyli extract 0.5~0.9%, sodium monofluorophosphate 0.5~0.6%, niacinamide 0.1~0.3%, the third two
Alcohol 3~4%, wintergreen 0.01~0.03%, caryophyllus oil 0.005~0.01%, tea oil 0.03~0.05%, sweetener
0.085~0.1%, lauryl sodium sulfate 0.6~0.8%, glycerol 12~15%, active zinc 0.05~0.07%, freshener
0.1~0.3%, thickener 1.5~1.8%, preservative 0.38~0.42%, buffer 0.1~0.2%, allantoin 0.3~
0.6%, surplus is deionized water.
Further, raw material are to extract containing Myrrha extract 2%, scutelloside 0.1%, tea polyphenols 0.3%, Radix zanthoxyli
Object 0.5%, niacinamide 0.1%, propylene glycol 3%, wintergreen 0.01%, caryophyllus oil 0.005%, tea oil 0.03%, sweetener
0.085%, glycerol 12%, lauryl sodium sulfate 0.6%, active zinc 0.05% mixing liquid state species.
Further, the active zinc is zinc gluconate, and the buffer is by sodium bicarbonate and Pfansteihl sodium two
Kind composition.
Further, the anti-anaphylaxis agent be 0.2~0.3% willow leaf calyx canthus extract, 0.1~0.2% scutelloside,
The mixture of 0.3~0.4% tea polyphenols composition.
Further, the sweetener is Sucralose, and the freshener is menthol, and the buffer is lemon
Lemon acid sodium, the thickener are corn carbohydrate gum.
Further, the mixture that the preservative forms for 0.15% potassium cinnamate and 0.23% triclosan.
Further, the preparation method of the canker sore nursing Essence includes the following steps:
1) it prepares mixing A: being heated to 60 DEG C using 30~35% deionized waters, will, 0.6~0.8% dodecyl sulphur
The dissolution of sour sodium, be put into triclosan, freshener, natural tea tree oil, natural winter-green oil, natural caryophyllus oil and propylene glycol sufficiently do mix it is mixed
Dissolution is closed, mixing A is made;
2) it prepares mixed material B: being dissolved allantoin with remaining deionized water, then constantly do to mix being respectively put into myrrh extraction
Object, scutelloside (be added 2 times of saturated solution of sodium bicarbonate), tea polyphenols, Radix Zanthoxyli extract, niacinamide, sweetener, active zinc,
Mixed material B is made in potassium cinnamate, buffer and thickener (first being dispersed with glycerol);
3) it is blended: by mixed material B obtained in mixing A made from step 1 and step 2, being sufficiently mixed and remaining increasing is added
Thick dose (first being dispersed with glycerol), be de-gassed to get dilute cream shape transparency liquid after moderate-speed mixer is uniform in a mixing bowl.
Further, the Myrrha extract, scutelloside, tea polyphenols and Radix Zanthoxyli extract must completely soluble shapes
At transparence solion state.
Further, scutelloside that the content is 0.2% Myrrha extract, content are 0.1%, content are
0.3% tea polyphenols, composition gold combination.
Further, scutelloside palpus content is 80~85%, and by extracting in natural radix scutellariae, the tea polyphenols
Content 85~95%, by extracting in natural leaf tea, the Myrrha extract must be Somalia's extract.
The present invention have it is below the utility model has the advantages that
1, quantitative single fluorine phosphorus sodium in solution of the present invention is completely dissolved in water, dissolves tooth hydroxyl phosphorus with fluorine ion state
Calcium ion in lime stone and serve mothproof.
2, it is combined by the gold of scutelloside, tea polyphenols and myrrh, there is high biological negative electricity lotus adsorption capacity.It is planted with atom
The heavy ulcer affected part blocking external substance that is attached to of object state enters, and plays anti-inflammatory analgetic, repairs the effect of holding back.Sensitive toothache can be prevented again.It is yellow
A kind of reed mentioned in ancient books glycosides, tea polyphenols, myrrh gold combine substance, have sterilizing inflammation-diminishing function, act the function of eliminating bad breath in the oral cavity.Its biology is negative
Charge is combined rapidly with the ulcer surface mucous membrane under isoelectric point, plays quickly alleviating pain, rapid repairing ulcer effect.
3, the present invention uses scutelloside, tea polyphenols, and the combination of myrrh gold is avoided using fungicide and steroids.In addition, yellow
A kind of reed mentioned in ancient books glycosides, tea polyphenols, the combination of myrrh gold is pure natural plant extract matter, has good biocompatibility, will not oral cavity group
The biological rejection reaction of generation is knitted, and can be absorbed by the body and utilize object to be beneficial.
4, canker sore nursing Essence provided by the invention can handle a variety of oral problems simultaneously, and effect is obvious and holds
The continuous time is long.The method that other treatment mouth diseases are substituted in the canker sore nursing comprehensive degree of essence, reduces oral cavity
Maintenance cost.
Specific embodiment
In order to make the object, technical scheme and advantages of the embodiment of the invention clearer, below in conjunction with the embodiment of the present invention,
Technical scheme in the embodiment of the invention is clearly and completely described, it is clear that described embodiment is the present invention one
Divide embodiment, instead of all the embodiments.Based on the embodiments of the present invention, those of ordinary skill in the art are not making
Every other embodiment obtained, shall fall within the protection scope of the present invention under the premise of creative work.
Embodiment 1:
Canker sore nurses Essence, wherein each material composition is by weight: Myrrha extract 3%, anti-anaphylaxis agent
0.6%, Radix Zanthoxyli extract 0.8%, sodium monofluorophosphate 0.5%, niacinamide 0.1%, propylene glycol 4%, wintergreen 0.02%, fourth
Sesame oil 0.005%, tea oil 0.03%, sweetener 0.085%, lauryl sodium sulfate 0.7%, glycerol 13%, active zinc
0.05%, freshener 0.3%, thickener 1.5%, preservative 0.38%, buffer 0.2%, allantoin 0.5%, surplus are to go
Ionized water.
Active zinc therein is zinc gluconate, and buffer is made of sodium bicarbonate and two kinds of Pfansteihl sodium.
Anti-anaphylaxis agent therein be 0.2% willow leaf calyx canthus extract, 0.1% scutelloside, 0.3% tea polyphenols composition
Mixture.
Sweetener therein is Sucralose, and freshener is menthol, and buffer is sodium citrate, and thickener is primverose
Glue.
Preservative therein is the mixture that 0.15% potassium cinnamate and 0.23% triclosan form.
The preparation method of canker sore nursing Essence therein includes the following steps:
1) it prepares mixing A: being heated to 60 DEG C using 33% deionized water, will, 0.7% lauryl sodium sulfate dissolution,
It is put into triclosan, freshener, natural tea tree oil, natural winter-green oil, natural caryophyllus oil and propylene glycol and sufficiently does and mix mixed dissolution, make
Obtain mixing A;
2) it prepares mixed material B: being dissolved allantoin with remaining deionized water, then constantly do to mix being respectively put into myrrh extraction
Object, scutelloside (be added 2 times of saturated solution of sodium bicarbonate), tea polyphenols, Radix Zanthoxyli extract, niacinamide, sweetener, active zinc,
Mixed material B is made in potassium cinnamate, buffer and thickener (first being dispersed with glycerol);
3) it is blended: by mixed material B obtained in mixing A made from step 1 and step 2, being sufficiently mixed and remaining increasing is added
Thick dose (first being dispersed with glycerol), be de-gassed to get dilute cream shape transparency liquid after moderate-speed mixer is uniform in a mixing bowl.
Myrrha extract, scutelloside, tea polyphenols and Radix Zanthoxyli extract therein must completely soluble formation transparences
Solion state.
Scutelloside palpus content therein is 82%, and by extracting in natural radix scutellariae, polyphenol content 88%, by natural leaf tea
Middle extraction, Myrrha extract must be Somalia's extract.
Embodiment 2:
Canker sore nurses Essence, wherein each material composition is by weight: Myrrha extract 2%, anti-anaphylaxis agent
0.6%, Radix Zanthoxyli extract 0.5%, sodium monofluorophosphate 0.5%, niacinamide 0.1%, propylene glycol 3%, wintergreen 0.01%, fourth
Sesame oil 0.005%, tea oil 0.03%, sweetener 0.085%, lauryl sodium sulfate 0.6%, glycerol 12%, active zinc
0.05%, freshener 0.1%, thickener 1.5%, preservative 0.38%, buffer 0.1%, allantoin 0.3%, surplus are to go
Ionized water.
Active zinc therein is zinc gluconate, and buffer is made of sodium bicarbonate and two kinds of Pfansteihl sodium.
Anti-anaphylaxis agent therein be 0.2% willow leaf calyx canthus extract, 0.1% scutelloside, 0.3% tea polyphenols composition
Mixture.
Sweetener therein is Sucralose, and freshener is menthol, and buffer is sodium citrate, and thickener is primverose
Glue.
Preservative therein is the mixture that 0.15% potassium cinnamate and 0.23% triclosan form.
The preparation method of canker sore nursing Essence therein includes the following steps:
1) it prepares mixing A: being heated to 60 DEG C using 30% deionized water, will, 0.6% lauryl sodium sulfate dissolution,
It is put into triclosan, freshener, natural tea tree oil, natural winter-green oil, natural caryophyllus oil and propylene glycol and sufficiently does and mix mixed dissolution, make
Obtain mixing A;
2) it prepares mixed material B: being dissolved allantoin with remaining deionized water, then constantly do to mix being respectively put into myrrh extraction
Object, scutelloside (be added 2 times of saturated solution of sodium bicarbonate), tea polyphenols, Radix Zanthoxyli extract, niacinamide, sweetener, active zinc,
Mixed material B is made in potassium cinnamate, buffer and thickener (first being dispersed with glycerol);
3) it is blended: by mixed material B obtained in mixing A made from step 1 and step 2, being sufficiently mixed and remaining increasing is added
Thick dose (first being dispersed with glycerol), be de-gassed to get dilute cream shape transparency liquid after moderate-speed mixer is uniform in a mixing bowl.
Myrrha extract, scutelloside, tea polyphenols and Radix Zanthoxyli extract therein must completely soluble formation transparences
Solion state.
Scutelloside palpus content therein is 80%, and by extracting in natural radix scutellariae, polyphenol content 90%, by natural leaf tea
Middle extraction, Myrrha extract must be Somalia's extract.
Embodiment 3:
Canker sore nurses Essence, wherein each material composition is by weight: Myrrha extract 2%, anti-anaphylaxis agent
0.8%, Radix Zanthoxyli extract 0.5%, sodium monofluorophosphate 0.6%, niacinamide 0.1%, propylene glycol 4%, wintergreen 0.01%, fourth
Sesame oil 0.01%, tea oil 0.05%, sweetener 0.09%, lauryl sodium sulfate 0.6%, glycerol 12%, active zinc
0.05%, freshener 0.1%, thickener 1.8%, preservative 0.42%, buffer 0.1%, allantoin 0.5%, surplus are to go
Ionized water.
Active zinc therein is zinc gluconate, and buffer is made of sodium bicarbonate and two kinds of Pfansteihl sodium.
Anti-anaphylaxis agent therein be 0.2% willow leaf calyx canthus extract, 0.2% scutelloside, 0.4% tea polyphenols composition
Mixture.
Sweetener therein is Sucralose, and freshener is menthol, and buffer is sodium citrate, and thickener is primverose
Glue.
Preservative therein is the mixture that 0.15% potassium cinnamate and 0.23% triclosan form.
The preparation method of canker sore nursing Essence therein includes the following steps:
1) it prepares mixing A: being heated to 60 DEG C using 32% deionized water, will, 0.7% lauryl sodium sulfate dissolution,
It is put into triclosan, freshener, natural tea tree oil, natural winter-green oil, natural caryophyllus oil and propylene glycol and sufficiently does and mix mixed dissolution, make
Obtain mixing A;
2) it prepares mixed material B: being dissolved allantoin with remaining deionized water, then constantly do to mix being respectively put into myrrh extraction
Object, scutelloside (be added 2 times of saturated solution of sodium bicarbonate), tea polyphenols, Radix Zanthoxyli extract, niacinamide, sweetener, active zinc,
Mixed material B is made in potassium cinnamate, buffer and thickener (first being dispersed with glycerol);
3) it is blended: by mixed material B obtained in mixing A made from step 1 and step 2, being sufficiently mixed and remaining increasing is added
Thick dose (first being dispersed with glycerol), be de-gassed to get dilute cream shape transparency liquid after moderate-speed mixer is uniform in a mixing bowl.
Myrrha extract, scutelloside, tea polyphenols and Radix Zanthoxyli extract therein must completely soluble formation transparences
Solion state.
Scutelloside palpus content therein is 84%, and by extracting in natural radix scutellariae, polyphenol content 92%, by natural leaf tea
Middle extraction, Myrrha extract must be Somalia's extract.
Embodiment 4:
Canker sore nurses Essence, wherein each material composition is by weight: Myrrha extract 4%, anti-anaphylaxis agent
0.9%, Radix Zanthoxyli extract 0.9%, sodium monofluorophosphate 0.6%, niacinamide 0.3%, propylene glycol 4%, wintergreen 0.03%, fourth
Sesame oil 0.01%, tea oil 0.05%, sweetener 0.1%, lauryl sodium sulfate 0.8%, glycerol 15%, active zinc
0.07%, freshener 0.3%, thickener 1.8%, preservative 0.42%, buffer 0.2%, allantoin 0.6%, surplus are to go
Ionized water.
Active zinc therein is zinc gluconate, and buffer is made of sodium bicarbonate and two kinds of Pfansteihl sodium.
Anti-anaphylaxis agent therein be 0.3% willow leaf calyx canthus extract, 0.2% scutelloside, 0.4% tea polyphenols composition
Mixture.
Sweetener therein is Sucralose, and freshener is menthol, and buffer is sodium citrate, and thickener is primverose
Glue.
Preservative therein is the mixture that 0.15% potassium cinnamate and 0.23% triclosan form.
The preparation method of canker sore nursing Essence therein includes the following steps:
1) it prepares mixing A: being heated to 60 DEG C using 35% deionized water, will, 0.8% lauryl sodium sulfate dissolution,
It is put into triclosan, freshener, natural tea tree oil, natural winter-green oil, natural caryophyllus oil and propylene glycol and sufficiently does and mix mixed dissolution, make
Obtain mixing A;
2) it prepares mixed material B: being dissolved allantoin with remaining deionized water, then constantly do to mix being respectively put into myrrh extraction
Object, scutelloside (be added 2 times of saturated solution of sodium bicarbonate), tea polyphenols, Radix Zanthoxyli extract, niacinamide, sweetener, active zinc,
Mixed material B is made in potassium cinnamate, buffer and thickener (first being dispersed with glycerol);
3) it is blended: by mixed material B obtained in mixing A made from step 1 and step 2, being sufficiently mixed and remaining increasing is added
Thick dose (first being dispersed with glycerol), be de-gassed to get dilute cream shape transparency liquid after moderate-speed mixer is uniform in a mixing bowl.
Myrrha extract, scutelloside, tea polyphenols and Radix Zanthoxyli extract therein must completely soluble formation transparences
Solion state.
Scutelloside palpus content therein is 85%, and by extracting in natural radix scutellariae, polyphenol content 95%, by natural leaf tea
Middle extraction, Myrrha extract must be Somalia's extract.
Embodiment 5:
Canker sore nurses Essence, wherein each material composition is by weight: Myrrha extract 3%, anti-anaphylaxis agent
0.6%, Radix Zanthoxyli extract 0.5%, sodium monofluorophosphate 0.5%, niacinamide 0.1%, propylene glycol 3%, wintergreen 0.01%, fourth
Sesame oil 0.007%, tea oil 0.04%, sweetener 0.088%, lauryl sodium sulfate 0.6%, glycerol 12%, active zinc
0.07%, freshener 0.1%, thickener 1.5%, preservative 0.42%, buffer 0.2%, allantoin 0.3%, surplus are to go
Ionized water.
Active zinc therein is zinc gluconate, and buffer is made of sodium bicarbonate and two kinds of Pfansteihl sodium.
Anti-anaphylaxis agent therein be 0.2% willow leaf calyx canthus extract, 0.1% scutelloside, 0.3% tea polyphenols composition
Mixture.
Sweetener therein is Sucralose, and freshener is menthol, and buffer is sodium citrate, and thickener is primverose
Glue.
Preservative therein is the mixture that 0.15% potassium cinnamate and 0.23% triclosan form.
The preparation method of canker sore nursing Essence therein includes the following steps:
1) it prepares mixing A: being heated to 60 DEG C using 33% deionized water, will, 0.6% lauryl sodium sulfate dissolution,
It is put into triclosan, freshener, natural tea tree oil, natural winter-green oil, natural caryophyllus oil and propylene glycol and sufficiently does and mix mixed dissolution, make
Obtain mixing A;
2) it prepares mixed material B: being dissolved allantoin with remaining deionized water, then constantly do to mix being respectively put into myrrh extraction
Object, scutelloside (be added 2 times of saturated solution of sodium bicarbonate), tea polyphenols, Radix Zanthoxyli extract, niacinamide, sweetener, active zinc,
Mixed material B is made in potassium cinnamate, buffer and thickener (first being dispersed with glycerol);
3) it is blended: by mixed material B obtained in mixing A made from step 1 and step 2, being sufficiently mixed and remaining increasing is added
Thick dose (first being dispersed with glycerol), be de-gassed to get dilute cream shape transparency liquid after moderate-speed mixer is uniform in a mixing bowl.
Myrrha extract, scutelloside, tea polyphenols and Radix Zanthoxyli extract therein must completely soluble formation transparences
Solion state.
Scutelloside palpus content therein is 85%, and by extracting in natural radix scutellariae, polyphenol content 90%, by natural leaf tea
Middle extraction, Myrrha extract must be Somalia's extract.
Medicinal experiment:
In October, 2017 and in October, 2018 respectively to 80, the canker sore patient outcome of 40 different selections every time
Test tracking.4 groups of patients are selected to nurse Essence to commercially available chlorhexidine lozenge, allusion quotation lozenge and containing steroids emplastrum canker sore
As a comparison, it carries out testing for 7 days.Selecting the treatment of chlorhexidine lozenge is A group, and selecting canker sore nursing Essence treatment is B group,
Selecting allusion quotation lozenge is C group.Selecting containing steroids emplastrum is D group.It is put on the skin respectively in canker sore affected part, wherein testing every group
10 people.In every 10 people, 6 to 12 years old 3 people.12 to 35 years old 4 people.36 to 75 years old 3 people.Male 7 people, 3 people of female, and every group wherein 6 people it is normal
Suffer from ulcer, 2 people are small to be had, and 2 people do not have.Women therein respectively accounts for 1 people in all ages and classes stage respectively.
It uses 1 minute initial trial: patient being allowed to illustrate that application method uses by each respectively.As a result following display:
1:1 minutes experimental test results of table
Group (people) | There is pain | Without pain |
A group | 7 | 3 |
B group | 0 | 10 |
C group | 8 | 2 |
D group | 1 | 9 |
It is tested by above-mentioned initial experiment, illustrates that nurse Essence containing canker sore provided by the invention has in the short time
There is analgesic sealing process.Therefore further, Essence is nursed to canker sore prepared by the present invention, carries out the effect that whole day is taken
Fruit test.
It was tested using 1 day to 2 days: patient being allowed to illustrate that application method uses by each respectively.As a result as follows:
Table 2:1 to 2 days experimental test result
Group (people) | There is pain | Without pain |
A group | 9 | 1 |
B group | 1 | 9 |
C group | 9 | 1 |
D group | 8 | 2 |
It was tested using 3 days: patient being allowed to illustrate that application method uses by each respectively.As a result as follows:
3:3 days experimental test results of table
Group (people) | There is pain | Without pain |
A group | 7 | 3 |
B group | 1 | 9 |
C group | 7 | 3 |
D group | 8 | 2 |
It was tested using 4 days: patient being allowed to illustrate that application method uses by each respectively.As a result as follows:
4:4 days experimental test results of table
Group (people) | There is pain | Without pain |
A group | 7 | 3 |
B group | 1 | 9 |
C group | 6 | 4 |
D group | 6 | 4 |
It was tested using 5 days: patient being allowed to illustrate that application method uses by each respectively.As a result as follows:
5:5 days experimental test results of table
Group (people) | There is pain | Without pain |
A group | 8 | 2 |
B group | 1 | 9 |
C group | 8 | 2 |
D group | 8 | 2 |
It was tested using 6 days: patient being allowed to illustrate that application method uses by each respectively.As a result as follows:
6:6 days experimental test results of table
Group (people) | There is pain | Without pain |
A group | 8 | 2 |
B group | 0 | 10 |
C group | 9 | 1 |
D group | 9 | 1 |
It is shown by the test result of above-mentioned short time and the medicinal test of prolonged multiple groups, oral cavity provided by the invention is burst
Ulcer nursing Essence truly has obvious curative effects to canker sore.
It should be noted that, in this document, relational terms such as first and second and the like are used merely to a reality
Body or operation are distinguished with another entity or operation, are deposited without necessarily requiring or implying between these entities or operation
In any actual relationship or order or sequence.Moreover, the terms "include", "comprise" or its any other variant are intended to
Non-exclusive inclusion, so that the process, method, article or equipment including a series of elements is not only wanted including those
Element, but also including other elements that are not explicitly listed, or further include for this process, method, article or equipment
Intrinsic element.In the absence of more restrictions, the element limited by sentence "including a ...", it is not excluded that
There is also other identical elements in process, method, article or equipment including element.
The above embodiments are merely illustrative of the technical solutions of the present invention, rather than its limitations;Although with reference to the foregoing embodiments
Invention is explained in detail, those skilled in the art should understand that: it still can be to aforementioned each implementation
Technical solution documented by example is modified or equivalent replacement of some of the technical features;And these modification or
Replacement, the spirit and scope for technical solution of various embodiments of the present invention that it does not separate the essence of the corresponding technical solution.
Claims (10)
1. canker sore nurses Essence, which is characterized in that wherein each material composition is by weight: Myrrha extract 2~
4%, anti-anaphylaxis agent 0.6~0.9%, Radix Zanthoxyli extract 0.5~0.9%, sodium monofluorophosphate 0.5~0.6%, niacinamide 0.1~
0.3%, propylene glycol 3~4%, wintergreen 0.01~0.03%, caryophyllus oil 0.005~0.01%, tea oil 0.03~0.05%,
Sweetener 0.085~0.1%, lauryl sodium sulfate 0.6~0.8%, glycerol 12~15%, active zinc 0.05~0.07%,
Freshener 0.1~0.3%, thickener 1.5~1.8%, preservative 0.38~0.42%, buffer 0.1~0.2%, allantoin
0.3~0.6%, surplus is deionized water.
2. canker sore according to claim 1 nurses Essence, it is characterised in that: raw material are to contain Myrrha extract
2%, scutelloside 0.1%, tea polyphenols 0.3%, Radix Zanthoxyli extract 0.5%, niacinamide 0.1%, propylene glycol 3%, wintergreen
0.01%, caryophyllus oil 0.005%, tea oil 0.03%, sweetener 0.085%, glycerol 12%, lauryl sodium sulfate 0.6%,
The mixing liquid state species of active zinc 0.05%.
3. canker sore according to claim 1 nurses Essence, it is characterised in that: the active zinc is gluconic acid
Zinc, the buffer are made of sodium bicarbonate and two kinds of Pfansteihl sodium.
4. canker sore according to claim 1 nurses Essence, it is characterised in that: the anti-anaphylaxis agent is 0.2~
0.3% willow leaf calyx canthus extract, 0.1~0.2% scutelloside, 0.3~0.4% tea polyphenols composition mixture.
5. canker sore according to claim 1 nurses Essence, it is characterised in that: the sweetener is trichlorine sugarcane
Sugar, the freshener are menthol, and the buffer is sodium citrate, and the thickener is corn carbohydrate gum.
6. canker sore according to claim 1 nurses Essence, it is characterised in that: the preservative is 0.15%
Potassium cinnamate and 0.23% triclosan composition mixture.
7. canker sore according to claim 1 nurses Essence, which is characterized in that preparation method includes the following steps:
1) it prepares mixing A: being heated to 60 DEG C using 30~35% deionized waters, will, 0.6~0.8% lauryl sodium sulfate
Dissolution, be put into triclosan, freshener, natural tea tree oil, natural winter-green oil, natural caryophyllus oil and propylene glycol sufficiently do mix mixing it is molten
Mixing A is made in solution;
2) it prepares mixed material B: allantoin being dissolved with remaining deionized water, then constantly does to mix being respectively put into Myrrha extract, Huang
A kind of reed mentioned in ancient books glycosides (2 times of saturated solution of sodium bicarbonate are added), tea polyphenols, Radix Zanthoxyli extract, niacinamide, sweetener, active zinc, cinnamic acid
Mixed material B is made in potassium, buffer and thickener (first being dispersed with glycerol);
3) it is blended: by mixed material B obtained in mixing A made from step 1 and step 2, being sufficiently mixed and remaining thickener is added
(first being dispersed with glycerol) is de-gassed after moderate-speed mixer is uniform in a mixing bowl to get dilute cream shape transparency liquid.
8. canker sore according to claim 7 nurses Essence, it is characterised in that: the Myrrha extract, radix scutellariae
Glycosides, tea polyphenols and Radix Zanthoxyli extract must completely soluble formation transparence solion states.
9. canker sore according to claim 7 nurses Essence, it is characterised in that: the content is 0.2% not have
The tea polyphenols that scutelloside that medicament extract, content are 0.1%, content are 0.3%, composition gold combination.
10. canker sore according to claim 7 nurses Essence, it is characterised in that: the scutelloside must content be
80~85%, and by being extracted in natural radix scutellariae, the polyphenol content 85~95% is described by extracting in natural leaf tea
Myrrha extract must be Somalia's extract.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910157509.XA CN109674875A (en) | 2019-03-01 | 2019-03-01 | Oral ulcer nursing essence |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910157509.XA CN109674875A (en) | 2019-03-01 | 2019-03-01 | Oral ulcer nursing essence |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109674875A true CN109674875A (en) | 2019-04-26 |
Family
ID=66197451
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910157509.XA Pending CN109674875A (en) | 2019-03-01 | 2019-03-01 | Oral ulcer nursing essence |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109674875A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110507813A (en) * | 2019-10-12 | 2019-11-29 | 德州学院 | Cure mainly the traditional Chinese medicine reagent and its preparation method of canker sore |
WO2022026672A1 (en) * | 2020-07-31 | 2022-02-03 | Colgate-Palmolive Company | Process for producing an oral care composition |
CN116172886A (en) * | 2022-06-29 | 2023-05-30 | 广州何济堂生物科技有限公司 | Mouthwash and preparation method thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108618980A (en) * | 2018-06-08 | 2018-10-09 | 叶绿芝生物科技(中山)有限公司 | A kind of multi-functional liquid tooth paste |
-
2019
- 2019-03-01 CN CN201910157509.XA patent/CN109674875A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108618980A (en) * | 2018-06-08 | 2018-10-09 | 叶绿芝生物科技(中山)有限公司 | A kind of multi-functional liquid tooth paste |
Non-Patent Citations (1)
Title |
---|
林荣欣: "牙膏配方暨产品知识面面观", 《牙膏工业》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110507813A (en) * | 2019-10-12 | 2019-11-29 | 德州学院 | Cure mainly the traditional Chinese medicine reagent and its preparation method of canker sore |
WO2022026672A1 (en) * | 2020-07-31 | 2022-02-03 | Colgate-Palmolive Company | Process for producing an oral care composition |
US11701314B2 (en) | 2020-07-31 | 2023-07-18 | Colgate-Palmolive Company | Processes and methods |
CN116172886A (en) * | 2022-06-29 | 2023-05-30 | 广州何济堂生物科技有限公司 | Mouthwash and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102579702B (en) | Medicine for treating dental ulcer and preparation method thereof | |
CN103536496B (en) | Toothpaste and preparation method thereof | |
CN104688648B (en) | A kind of composition for oral cavity and preparation method thereof | |
CN105310960B (en) | A kind of novel polysaccharide antimicrobial mouthwash and preparation method thereof | |
CN109674875A (en) | Oral ulcer nursing essence | |
CN106420493A (en) | Hyaluronic acid toothpaste with effects of diminishing inflammation and inhibiting bacteria and preparation method of hyaluronic acid toothpaste | |
CN104688786B (en) | A kind of externally-applied medicinal composition and its preparation method and application | |
CN107811890A (en) | A kind of oral cavity caring toothpaste composition | |
CN103908491B (en) | A kind of composition for treating tinea pedis foot odour and preparation method thereof | |
CN106580822A (en) | Plant acne-removing compound as well as preparation method and applications thereof | |
CN111973515A (en) | Bacteriostatic restoration plant extraction composition, preparation method and application thereof | |
CN111743986A (en) | Gynecological gel and preparation method thereof | |
CN111759885A (en) | Sophora flavescens composition, sophora flavescens gel and preparation method thereof | |
CN108635378A (en) | A kind of mouth sprays and preparation method thereof for common oral health maintenance | |
CN102085369B (en) | Medical gel product for xerostomia and preparation method thereof | |
CN106726896A (en) | A kind of beautifying health composition with anti-inflammatory bacteriostasis efficacy and preparation method thereof | |
WO2016010284A1 (en) | Toothpaste composition containing curcuma longa l., and preparation method therefor | |
CN106974866A (en) | A kind of folium artemisiae argyi formula toothpaste and preparation method thereof | |
CN106309746A (en) | Traditional Chinese medicine composition, preparation method thereof and oral health product | |
CN114306526B (en) | Compound broadleaf holly leaf traditional Chinese medicine extract and application thereof in preparing shower gel or hand sanitizer | |
CN103599182A (en) | Traditional Chinese medicine composition and preparation method thereof, and oral cavity cleaning and nursing product and preparation method thereof | |
KR20200118322A (en) | Cleanser for women and methods for manufacturing the same | |
CN105287328A (en) | Manuka honey toothpaste for pregnant women and preparation method of toothpaste | |
CN103191159B (en) | Inflammation-diminishing bacterium-inhibition preparation and its preparation method and use | |
CN106236645A (en) | A kind of natural child's collutory |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 528437 1901, floor 19, building B, Zhongshan creative port, No. 25, Gangyi Road, Torch Development Zone, Zhongshan City, Guangdong Province Applicant after: Guangdong yikoukang Technology Co.,Ltd. Address before: 528400 room 4, 1105, building 3, sanbaihui Plaza, No. 8, Torch Road, Torch Development Zone, Zhongshan City, Guangdong Province Applicant before: ZHONGSHAN YIKOUKANG TECHNOLOGY Co.,Ltd. |
|
CB02 | Change of applicant information |